Free-cash-flow margin moved 2461 bp lower
Free-cash-flow margin changed -2461 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-17.58%→-42.19%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RXST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 2200 bp lower
Operating cash-flow margin changed -2200 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-13.01%→-35.01%2 prior comparisons
Receivables / revenue moved 1543 bp lower
Receivables / revenue changed -1543 basis points from the comparable as-filed period.
83.41%→67.98%2 prior comparisons
Current assets increased 15.3%
Current assets changed +15.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$283.9M→$327.4M4 prior comparisons
Total assets increased 14.1%
Total assets changed +14.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$309.0M→$352.7M4 prior comparisons
Capital expenditure increased 27.3%
Capital expenditure changed +27.3% from the comparable as-filed period.
$1.5M→$2.0M3 prior comparisons
R&D / revenue moved 353 bp higher
R&D / revenue changed +353 basis points from the comparable as-filed period.
30.37%→33.91%2 prior comparisons
SBC / revenue moved 199 bp higher
SBC / revenue changed +199 basis points from the comparable as-filed period.
25.41%→27.40%2 prior comparisons
Stock-based compensation decreased 12.7%
Stock-based compensation changed -12.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$8.5M→$7.5M3 prior comparisons
Research & development decreased 9.6%
Research & development changed -9.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$10.2M→$9.2M2 prior comparisons
Working capital decreased 6.3%
Working capital changed -6.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$263.5M→$247.0M4 prior comparisons
Shares outstanding increased 1.7%
Shares outstanding changed +1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
40,915,963→41,593,2568 prior comparisons
Selling, general & administrative increased 5.0%
Selling, general & administrative changed +5.0% from the comparable as-filed period.
$29.0M→$30.4M2 prior comparisons
Operating income increased 1.7%
Operating income changed +1.7% from the comparable as-filed period.
-$14.0M→-$13.8M2 prior comparisons
Cost of revenue decreased 7.0%
Cost of revenue changed -7.0% from the comparable as-filed period.
$8.4M→$7.9M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.